Q4 2024 |
97 |
$3.59B |
+$284M |
-$930M |
-$646M |
VRNA, ACLX, FOLD, RYTM, NUVL
|
13F-HR |
2/14/2025, 04:09 PM |
Q3 2024 |
102 |
$4.66B |
+$695M |
-$898M |
-$202M |
ACLX, NUVL, FOLD, IOVA, PCVX
|
13F-HR |
11/14/2024, 04:10 PM |
Q2 2024 |
107 |
$4.14B |
+$409M |
-$1.11B |
-$706M |
CERE, FOLD, ACLX, IOVA, NUVL
|
Restatement |
8/16/2024, 04:10 PM |
Q1 2024 |
105 |
$5.67B |
+$1.46B |
-$627M |
+$835M |
CERE, FOLD, IOVA, ACLX, NUVL
|
Restatement |
8/6/2024, 05:06 PM |
Q4 2023 |
97 |
$4.47B |
+$885M |
-$394M |
+$491M |
CERE, FOLD, LIAN, ACLX, NUVL
|
Restatement |
2/23/2024, 07:00 PM |
Q3 2023 |
108 |
$2.99B |
+$396M |
-$554M |
-$157M |
FOLD, CERE, IMVT, ACLX, NUVL
|
13F-HR |
11/14/2023, 04:14 PM |
Q2 2023 |
115 |
$3.45B |
+$665M |
-$846M |
-$181M |
FOLD, CERE, LIAN, ACLX, AMLX
|
Restatement |
8/24/2023, 05:10 PM |
Q1 2023 |
99 |
$3.39B |
+$690M |
-$250M |
+$440M |
FOLD, RETA, AMLX, CERE, MDGL
|
Restatement |
5/16/2023, 03:29 PM |
Q4 2022 |
94 |
$3.56B |
+$714M |
-$206M |
+$508M |
FOLD, AMLX, MDGL, CERE, RXDX
|
13F-HR |
2/14/2023, 03:18 PM |
Q3 2022 |
115 |
$3.45B |
+$601M |
-$244M |
+$357M |
FOLD, MRTX, CERE, GBT, AMLX
|
13F-HR |
11/14/2022, 03:24 PM |
Q2 2022 |
110 |
$3.19B |
+$292M |
-$408M |
-$116M |
FOLD, MRTX, CERE, IOVA, LIAN
|
13F-HR |
8/15/2022, 04:49 PM |
Q1 2022 |
133 |
$4.81B |
+$868M |
-$407M |
+$462M |
FOLD, SWTX, LIAN, IOVA, MRTX
|
13F-HR |
5/16/2022, 04:31 PM |
Q4 2021 |
145 |
$6.47B |
|
|
|
MRTX, LIAN, FOLD, SWTX, IOVA
|
New Holdings |
5/4/2022, 10:18 AM |
Q4 2021 |
145 |
$6.47B |
+$973M |
-$301M |
+$671M |
MRTX, LIAN, FOLD, SWTX, IOVA
|
Restatement |
4/13/2022, 04:24 PM |
Q3 2021 |
138 |
$6.86B |
+$585M |
-$876M |
-$290M |
MRTX, BBIO, SWTX, IOVA, FOLD
|
Restatement |
12/3/2021, 03:34 PM |
Q2 2021 |
148 |
$7.69B |
$0 |
$0 |
|
MRTX, BBIO, SWTX, IOVA, FOLD
|
New Holdings |
8/17/2021, 09:17 AM |
Q2 2021 |
148 |
$7.69B |
+$1.03B |
-$605M |
+$422M |
MRTX, BBIO, SWTX, IOVA, FOLD
|
13F-HR |
8/16/2021, 04:36 PM |
Q1 2021 |
136 |
$7.52B |
+$918M |
-$1.46B |
-$542M |
MRTX, BBIO, SWTX, IOVA, FOLD
|
Restatement |
8/13/2021, 05:01 PM |
Q4 2020 |
138 |
$9.32B |
+$2.04B |
-$143M |
+$1.89B |
MRTX, FOLD, BBIO, IOVA, NVTA
|
13F-HR |
2/16/2021, 03:32 PM |
Q3 2020 |
125 |
$6.82B |
+$1.18B |
-$394M |
+$782M |
MRTX, FOLD, IOVA, GBT, BBIO
|
13F-HR |
11/16/2020, 03:35 PM |
Q2 2020 |
123 |
$6.14B |
+$1.32B |
-$328M |
+$994M |
FOLD, GBT, IOVA, MRTX, NBIX
|
Restatement |
8/17/2020, 11:00 AM |
Q1 2020 |
108 |
$3.82B |
+$492M |
-$190M |
+$301M |
IOVA, GBT, NBIX, MRTX, FOLD
|
Restatement |
5/18/2020, 12:10 PM |
Q4 2019 |
113 |
$4.89B |
+$493M |
-$222M |
+$272M |
GBT, MRTX, NBIX, KOD, IOVA
|
Restatement |
2/19/2020, 04:03 PM |
Q3 2019 |
106 |
$3.67B |
+$386M |
-$154M |
+$232M |
NBIX, GBT, MRTX, IOVA, FOLD
|
13F-HR |
11/14/2019, 03:50 PM |
Q2 2019 |
102 |
$4.33B |
+$903M |
-$341M |
+$562M |
NBIX, GBT, MRTX, IOVA, FOLD
|
13F-HR |
8/14/2019, 05:18 PM |
Q1 2019 |
104 |
$3.54B |
+$586M |
-$89M |
+$496M |
NBIX, FOLD, GBT, ZGNX, AMRN
|
Restatement |
5/15/2019, 07:52 PM |
Q4 2018 |
94 |
$2.53B |
+$541M |
-$213M |
+$328M |
NBIX, GBT, FOLD, ZGNX, IOVA
|
13F-HR |
2/14/2019, 03:30 PM |
Q3 2018 |
114 |
$3.66B |
+$474M |
-$312M |
+$161M |
NBIX, FOLD, GBT, ZGNX, ALNY
|
13F-HR |
11/14/2018, 04:00 PM |
Q2 2018 |
118 |
$3.69B |
+$517M |
-$367M |
+$150M |
NBIX, FOLD, GBT, ALNY, ZGNX
|
Restatement |
11/1/2018, 05:16 PM |
Q1 2018 |
132 |
$3.53B |
+$738M |
-$268M |
+$470M |
NBIX, FOLD, GBT, ZGNX, ALNY
|
13F-HR |
5/15/2018, 04:19 PM |
Q4 2017 |
131 |
$3.02B |
+$572M |
-$182M |
+$390M |
NBIX, FOLD, GBT, ALNY, ZGNX
|
13F-HR |
2/14/2018, 04:59 PM |
Q3 2017 |
130 |
$2.59B |
+$441M |
-$86.3M |
+$355M |
NBIX, FOLD, ALNY, GBT, ZGNX
|
Restatement |
11/14/2017, 04:20 PM |
Q2 2017 |
124 |
$1.97B |
+$469M |
-$130M |
+$339M |
FOLD, NBIX, ALNY, GBT, VSAR
|
13F-HR |
8/14/2017, 04:33 PM |
Q1 2017 |
155 |
$1.74B |
+$391M |
-$165M |
+$226M |
NBIX, GBT, FOLD, VSAR, LJPC
|
13F-HR |
5/15/2017, 04:36 PM |
Q4 2016 |
177 |
$1.41B |
+$311M |
-$107M |
+$204M |
NBIX, TSRO, FOLD, SRPT, VSAR
|
Restatement |
5/2/2017, 04:31 PM |
Q3 2016 |
186 |
$1.53B |
+$268M |
-$203M |
+$65.3M |
SRPT, NBIX, FOLD, TSRO, RTRX
|
13F-HR |
11/14/2016, 03:36 PM |
Q2 2016 |
170 |
$1.43B |
+$426M |
-$71.2M |
+$355M |
SRPT, NBIX, TSRO, FOLD, SRPT
|
13F-HR |
8/11/2016, 02:38 PM |
Q1 2016 |
167 |
$1.14B |
+$295M |
-$46M |
+$249M |
FOLD, NBIX, SRPT, TSRO, AGN
|
13F-HR |
5/16/2016, 04:32 PM |
Q4 2015 |
155 |
$1.35B |
+$229M |
-$83.6M |
+$145M |
FOLD, NBIX, SRPT, DYAX, TSRO
|
13F-HR |
2/16/2016, 03:59 PM |
Q3 2015 |
152 |
$1.24B |
|
|
|
FOLD, NBIX, SRPT, RTRX, TSRO
|
New Holdings |
11/17/2015, 09:11 AM |
Q3 2015 |
152 |
$1.24B |
+$288M |
-$111M |
+$177M |
FOLD, NBIX, SRPT, RTRX, TSRO
|
13F-HR |
11/16/2015, 03:30 PM |
Q2 2015 |
171 |
$1.63B |
+$396M |
-$151M |
+$245M |
FOLD, NBIX, RTRX, SRPT, TSRO
|
13F-HR |
8/14/2015, 04:31 PM |
Q1 2015 |
155 |
$1.28B |
+$288M |
-$166M |
+$122M |
FOLD, NBIX, RTRX, TSRO, RLYP
|
13F-HR |
5/15/2015, 04:31 PM |
Q4 2014 |
148 |
$1.19B |
+$354M |
-$168M |
+$186M |
FOLD, NBIX, ACRXXXXX, SRPT, RLYP
|
13F-HR |
2/17/2015, 03:01 PM |
Q3 2014 |
120 |
$887M |
+$235M |
-$152M |
+$82.5M |
FOLD, NBIX, SRPT, ACRXXXXX, CELG
|
Restatement |
11/17/2014, 11:30 AM |
Q2 2014 |
116 |
$1.02B |
+$333M |
-$143M |
+$190M |
SRPT, NBIX, ACRXXXXX, VRTX, CELG
|
13F-HR |
8/14/2014, 04:00 PM |
Q1 2014 |
126 |
$952M |
+$338M |
-$169M |
+$169M |
ACRXXXXX, NBIX, SRPT, VRTX, TSRO
|
13F-HR |
5/15/2014, 04:00 PM |
Q4 2013 |
107 |
$827M |
|
|
|
CELG, ACRXXXXX, SRPT, VRTX, TSRO
|
13F-HR |
2/14/2014, 03:33 PM |